Mohamad Gharehdaghi
Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
[ 1 ] - Denosumab in Patients with Giant Cell Tumor and Its Recurrence: A Systematic Review
Recent studies suggest that Denosumab reduces tumor size, therefore, makes the surgery easier with lowermorbidity. However, some studies have reported several complications for this drug. So, this systematic reviewwas performed to determine the effectiveness and safety of Denosumab in reducing bone destructions activity ofgiant cell tumor and skeletal-related events (SRE) in affected patients w...
Co-Authors